Bids are Invited For E RE 63 Itopride 150 mg ER SRPLUSPantoprazole 40mg,E RE 63 Dispo IV fi hand disposable 6 7 cm,E RE in DARJEELING, WEST BENGAL

The eligibility requirements typically include being a registered pharmaceutical entity, possessing valid licenses for drug manufacturing, compliance with health and safety regulations, and financial stability to fulfill the order.

Bidders are required to submit certificates of registration, drug manufacturing licenses, quality compliance certifications, and any other relevant documentation that demonstrates their capability to deliver the required products.

Interested bidders must register on the relevant procurement portal. This involves filling out registration forms, providing necessary documentation, and verifying their credentials as a registered pharmaceutical supplier to participate in the tender process.

Only specific formats prescribed in the tender documentation will be accepted. Bidders must ensure that all submitted documents are in the required electronic formats, as detailed in the linked documents.

The technical specifications detail the exact formulation, quality benchmarks, packaging requirements, and labeling standards that all products must conform to. This information is crucial for compliance with health regulations and can be found in the linked documents.

Bidders must adhere to national and international quality standards relevant to pharmaceutical products, ensuring that all medications are safe, effective, and meet regulatory requirements for military healthcare.

Yes, compliance with the Make in India policies and international quality assurance protocols is expected. Bidders must ensure that their products meet all regulatory requirements mandated by the appropriate health authorities.

The Earnest Money Deposit (EMD) details will be specified in the tender documentation. This amount serves as a security measure for the tender process and demonstrates the bidder's commitment.

Bidders may be required to furnish performance security depending on the tender's financial implications, which will be outlined thoroughly in the tender documentation.

Payment terms must be clearly outlined in the tender response, and typically involve post-delivery payments or milestone payments based on delivery and verification of the products.

Pricing evaluations will be based on the item-wise evaluation method where each product's price will be considered in context with its compliance to the specifications and overall bid competitiveness.

Bids should be submitted electronically through the designated procurement portal, following all prescribed formats and guidelines as outlined in the tender documentation.

Specific timelines and deadlines for the bidding process will be defined in the tender; it's essential for bidders to adhere strictly to submission guidelines and timelines to remain competitive.

The evaluation process consists of a comprehensive review of compliance with technical specifications, financial evaluations, and bidders' past performance records, ensuring that the most qualified bidders are selected.

Results will be communicated through the procurement portal following completion of the evaluation process. Bidders are encouraged to regularly check the portal for updates.

Yes, benefits for MSEs include financial assistance, potential price preference during evaluation, and other supportive measures aimed at enhancing competition and participation.

Startups may benefit from special provisions that could include relaxed eligibility criteria, access to funding, and support programs aimed at fostering innovation and participation in government procurement.

The tender encourages local manufacturing and procurement, aligning with the Make in India initiative, which aims to promote domestic production and reduce reliance on imports, fostering economic growth in the pharmaceutical sector.